Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Nachury

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Gastroenterologie Clinique Et Biologique|January 27, 2005
[Early anocutaneous metastases of rectal cancer after transanal resection with stapled anastomosis]Céline Delluc, Jean-Marc Gornet, Pierre Cattan, et al.
Cutis|February 17, 2017
Severe Henoch-Schönlein purpura complicating infliximab therapy for ulcerative colitisClaire Laresche, Fanny Locatelli, Caroline Biver-Dalle, et al.
Human Pathology|May 14, 2005
Acute hepatitis E: a cause of lymphocytic destructive cholangitisDominique Wendum, Maria Nachury, Matthieu Yver, et al.
Gastroenterologie Clinique Et Biologique|August 4, 2006
[Meckel's diverticulum with lower digestive hemorrhage and perforation]Marion Simon, Jean-Marc Gornet, Véronique Veuillez, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 25, 2026
Transition practices of patients with inflammatory bowel disease from pediatric to adult healthcare systems. Results from a national surveyJustine Leruste, Delphine Ley, Frédéric Gottrand, et al.
Therapeutic Advances in Gastroenterology|April 29, 2025
Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational studyGabrielle D'Abbundo, Maria Nachury, Alice Wartski, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 1, 2016
Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumabNicolas Duveau, Maria Nachury, Romain Gerard, et al.
Inflammatory Bowel Diseases|April 10, 2024
Changes Over Time in the Lémann Index and the Inflammatory Bowel Disease Disability Index in a Prospective Cohort of Patients With Crohn's DiseaseLaurine Cartier, Apolline Loiez, Maria Nachury, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2020
Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation studyFerdinando D'Amico, Laurent Peyrin-Biroulet, Luc Vandromme, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2020
Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability IndexClémentine Lauriot Dit Prevost, Mustapha Azahaf, Maria Nachury, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Gastroenterologie Clinique Et Biologique|January 27, 2005
[Early anocutaneous metastases of rectal cancer after transanal resection with stapled anastomosis]Céline Delluc, Jean-Marc Gornet, Pierre Cattan, et al.
Cutis|February 17, 2017
Severe Henoch-Schönlein purpura complicating infliximab therapy for ulcerative colitisClaire Laresche, Fanny Locatelli, Caroline Biver-Dalle, et al.
Human Pathology|May 14, 2005
Acute hepatitis E: a cause of lymphocytic destructive cholangitisDominique Wendum, Maria Nachury, Matthieu Yver, et al.
Gastroenterologie Clinique Et Biologique|August 4, 2006
[Meckel's diverticulum with lower digestive hemorrhage and perforation]Marion Simon, Jean-Marc Gornet, Véronique Veuillez, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 25, 2026
Transition practices of patients with inflammatory bowel disease from pediatric to adult healthcare systems. Results from a national surveyJustine Leruste, Delphine Ley, Frédéric Gottrand, et al.
Therapeutic Advances in Gastroenterology|April 29, 2025
Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational studyGabrielle D'Abbundo, Maria Nachury, Alice Wartski, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 1, 2016
Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumabNicolas Duveau, Maria Nachury, Romain Gerard, et al.
Inflammatory Bowel Diseases|April 10, 2024
Changes Over Time in the Lémann Index and the Inflammatory Bowel Disease Disability Index in a Prospective Cohort of Patients With Crohn's DiseaseLaurine Cartier, Apolline Loiez, Maria Nachury, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2020
Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation studyFerdinando D'Amico, Laurent Peyrin-Biroulet, Luc Vandromme, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2020
Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability IndexClémentine Lauriot Dit Prevost, Mustapha Azahaf, Maria Nachury, et al.
Pageof 10